Are you Dr. Sofuoglu?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 22 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
950 Campbell Ave
Bldg 36
West Haven, CT 06516Phone+1 203-937-4809
Summary
- Dr. Mehmet Sofuoglu, MD is a board certified psychiatrist in West Haven, Connecticut. He is currently licensed to practice medicine in Connecticut, Pennsylvania, and New York. He is affiliated with Veterans Affairs Connecticut Healthcare System and is an Associate Professor at Yale University School of Medicine.
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityResidency, Psychiatry, 1993 - 1995
- University of MinnesotaResidency, Psychiatry, 1991 - 1993
- Hacettepe University FOMClass of 1984
Certifications & Licensure
- CA State Medical License 1993 - Present
- CT State Medical License 2001 - 2025
- PA State Medical License 2008 - 2008
- NY State Medical License 2000 - 2002
- MN State Medical License 1995 - 2000
- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Effect of Progesterone on Smoking Behavior in Male and Female Smokers Start of enrollment: 2004 Sep 01
- Cocaine Withdrawal and Pharmacotherapy Response Start of enrollment: 2007 Sep 01
- Galantamine Effects on Cognitive Function in Abstinent Cocaine Users Start of enrollment: 2007 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 9 citationsRandomized placebo-controlled trial of galantamine in individuals with cocaine use disorderElise E. DeVito, Kathleen M. Carroll, Theresa Babuscio, Charla Nich, Mehmet Sofuoglu
Journal of Substance Abuse Treatment. 2019-12-01 - 22 citationsEffects of galantamine on cocaine use in chronic cocaine users.Mehmet Sofuoglu, Kathleen M. Carroll
The American Journal on Addictions. 2011-05-01 - 14 citationsDouble‐Blind Placebo‐Controlled Trial of Galantamine for Methadone‐Maintained Individuals With Cocaine Use Disorder: Secondary Analysis of Effects on Illicit Opioid UseKathleen M. Carroll, Elise E. DeVito, Sarah W. Yip, Charla Nich, Mehmet Sofuoglu
The American Journal on Addictions. 2019-07-01
Press Mentions
- Are Hormones Responsible for Your Addiction?June 11th, 2017
Grant Support
- Cognitive Enhancement As A Target For Cocaine PharmacotherapyNational Institute On Drug Abuse2011–2012
- Progesterone For Postpartum Cocaine RelapseNational Institute On Drug Abuse2010–2011
- Human Laboratory Studies For Stimulant AddictionNational Institute On Drug Abuse2008–2011
- Sensitivity To Intravenous Nicotine: Genetic ModeratorsNational Institute On Drug Abuse2009–2010
- Cocaine Withdrawal And Pharmacotherapy ResponseNational Institute On Drug Abuse2007–2010
- GABA Medications For Tobacco AddictionNational Institute On Drug Abuse2006–2009
- GABA Medications And Cocaine Interaction In HumansNational Institute On Drug Abuse2007
- GABA Medications And Cocaine Interactions In HumansNational Institute On Drug Abuse2006
- Progestrone And The Effects Of NicotineNational Institute On Drug Abuse2003–2006
- GABA Medications And Cocaine Interactions In HumansNational Institute On Drug Abuse2004–2005
- Progesterone Treatment On Effects Of Stimulants In FemalesNational Center For Research Resources2000–2002
- Stress Hormones And Human Cocaine Use--Effects Of LabetalolNational Center For Research Resources1998–1999
- Stress Hormones And Human Cocaine UseNational Center For Research Resources1998–1999